The validity of the captopril test for primary aldosteronism (PA) was tested in patients with surgically verified PA (n=12) or essential hypertension (EHT, n=20) with different levels of sodium intakes. The patients were scheduled on 7 days each of three regimes of the prepared diet containing 34, 120 and 340mEq of sodium chloride per day, and the captopril test was repeated in each period. For the test, captopril (50mg) was administered orally at 9:00A.M. after 1 hour of rest in a supine position, and venous blood samples were obtained before and 90min after drug administration.
Although the depressor effects of captopril were smaller in patients with PA than with EHT, there was considerable variance in the % decrease of MBP in the 2 groups. No patients had complaints due to antihypertensive effects of the drug. The basal PRA values varied from 0.1 to 1.2ng/ml/h in patients with PA and 0.1 to 3.0ng/ml/h in patients with EHT on the normal sodium diet (Table II) . However, the PRA values after captopril were below 0.5ng/ml/h in 9 of 12 patients with PA and 2 of 20 patients with EHT (Fig.  1) . Under the low sodium diet, 3 of 4 PA patients showed blunted PRA levels, which were common during the high sodium diet not only in patients with PA but in those with EHT.
The basal PAC on the normal sodium diet was greater than 15ng/dl in 10 patients with PA and 3 patients with EHT (Table II) . On the normal sodium diet, the PACs 90min after captopril were below 15ng/dl in all patients with EHT, whereas those were still greater than 15ng/dl in 10 of 12 patients with PA (Fig.2) . During the low sodium diet, all patients with PA and 3 of 20 patients with EHT had a PAC greater than 15ng/dl after J pn. Heart J. captopril. On the other hand, the PAC was greater than 15ng/dl in all of the PA patients but not in the EHT patients during the high sodium diet.
The PAC/PRA ratio after captopril was less than 20 in all of EHT patients on the normal and low sodium diet (Fig.3) .
During the high sodium diet, the ratios after captopril were greater than 20 in 5 patients with EHT. However, their PACs were always below 15ng/dl. By contrast, all patients with PA had ratios greater than 20 after captopril administration on the normal and high sodium diet. However, one of 4 patients with PA had a ratio less than 20 on the low sodium diet. Table III shows the sensitivity and the specificity of the tests. The sensitivity was defined as the likelihood of a positive test result in a person with disease, and the specificity was defined as the likelihood of a negative test result in a person without disease.4) A PAC/PRA ratio greater than 20 after captopril showed the highest sensitivity and specificity in patients with PA. A PAC value greater than 15ng/dl had similar sensitivity and specificity. A combination of the ratio of PAC/PRA and/or PAC value yielded 100% accuracy to the specificity or sensitivity for screening PA. Vol.28 No.3 SODIUM EFFECTS ON THE CAPTOPRIL TEST 363 Fig.3 . The ratio of plasma aldosterone concentration (PAC; ng/dl) to plasma renin activity (PRA; ng/ml/h) 90min after oral administration of 50mg captopril under the normal, low and high sodium diets. Patient identification as in Fig.1 .
The horizontal bars express the mean values of each group. 
DISCUSSION
In the present study, the usefulness of the captopril test to screen patients with PA was evaluated and the effects of sodium intake on the diagnostic sensitivity and specificity were examined.
A PAC/PRA ratio greater than 20 at 90min after oral administration of 50mg captopril was a useful tool Jpn. Heart J. May 1987 for detecting PA. In our outpatient clinic, suppressed PRA after furosemide i .v. and a 2 hour standing load (renin stimulation test) has been used as a test for PA; however, it diagnostic specificity is unsatisfactory.3),5) This may also be true for repeated measurements of serum potassium.6) Especially in Japan , mild hypokalemia (<3.5mEq/l) is found in 12% (9/75) of EHT patients.7) This is probably due to a higher dietary sodium intake, which is twice as high as in American patients.8)
Recently, Lyons et al2) have reported that a single dose of captopril was a highly specific test for PA. Captopril lowers angiotensin II levels and decreases aldosterone production in patients with EHT, but it has no effect on aldosterone production independent from the renin-angiotensin aldosterone system (RAA) in patients with PA. Since the RAA system is influenced by the amount of sodium ingestion, there is a potential problem in applying the captopril test to out-patients with varying levels of sodium intake. Therefore, it is necessary to examine whether the sodium deprivation or loading affects the sensitivity and specificity of the test in the diagnosis of PA.
As shown in our previous research,3) a PAC/PRA ratio greater than 20 on a normal sodium diet appears to be sufficient to diagnose PA. Furthermore, a ratio greater than 20 and a PAC value above 15ng/dl after captopril provided the adequate sensitivity and specificity despite sodium intake (Table III) . These findings are in good agreement with those of Bravo et al.8) In addition, the combination of PAC/PRA and/or PAC after captopril provided sufficient specificity or sensitivity.
The present study did not address the possibility of distinguishing subtypes of PA. Mantero et al9) reported a partial dependency of aldosterone secretion upon the renin-angiotensin system in patients with idiopathic hyperaldosteronism. These results, obtained after oral administration of captopril at a dose of 75mg per day for 1 week, suggested that the disease was a clinical entity different from aldosterone producing adenoma. In addition, Lyons et al2) reported that a nomogram consisted of the PAC/PRA ratio and the PAC value at 120min after a single dose of 25mg captopril could not differenciate subtypes of PA. Unfortunately, we had no case with idiopathic hyperaldosteronism. However, it is important to note that 2 patients with PA were intially diagnosed as idiopathic hyperaldosteronism, because of a lack of evidence existing adenoma by the standard localizing procedures. Afterward, small adenomas in both cases have been demonstrated by repeated evaluation in surgery. In conclusion, the captopril test may be safe and useful for identifying patients with PA, independent of their daily sodium intake. Vol.28 No. 3 SODIUM EFFECTS ON THE CAPTOPRIL TEST 365
